Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment
Publication
, Conference
Price, J; Shantzer, L; Jacobs, CD; Niedzwiecki, D; Clarke, J; Kelsey, CR; Salama, JK; Torok, JA
Published in: International Journal of Radiation Oncology*Biology*Physics
September 2019
Duke Scholars
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2019
Volume
105
Issue
1
Start / End Page
E527 / E527
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Price, J., Shantzer, L., Jacobs, C. D., Niedzwiecki, D., Clarke, J., Kelsey, C. R., … Torok, J. A. (2019). Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment. In International Journal of Radiation Oncology*Biology*Physics (Vol. 105, pp. E527–E527). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2019.06.2429
Price, J., L. Shantzer, C. D. Jacobs, D. Niedzwiecki, J. Clarke, C. R. Kelsey, J. K. Salama, and J. A. Torok. “Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment.” In International Journal of Radiation Oncology*Biology*Physics, 105:E527–E527. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2429.
Price J, Shantzer L, Jacobs CD, Niedzwiecki D, Clarke J, Kelsey CR, et al. Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019. p. E527–E527.
Price, J., et al. “Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment.” International Journal of Radiation Oncology*Biology*Physics, vol. 105, no. 1, Elsevier BV, 2019, pp. E527–E527. Crossref, doi:10.1016/j.ijrobp.2019.06.2429.
Price J, Shantzer L, Jacobs CD, Niedzwiecki D, Clarke J, Kelsey CR, Salama JK, Torok JA. Radiation Therapy Prior to Immune Checkpoint Inhibition in Metastatic Non-Small Cell Lung Cancer: Determining Toxicity and Efficacy of Combination Treatment. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2019. p. E527–E527.
Published In
International Journal of Radiation Oncology*Biology*Physics
DOI
ISSN
0360-3016
Publication Date
September 2019
Volume
105
Issue
1
Start / End Page
E527 / E527
Publisher
Elsevier BV
Related Subject Headings
- Oncology & Carcinogenesis
- 5105 Medical and biological physics
- 3407 Theoretical and computational chemistry
- 3211 Oncology and carcinogenesis